Open access
Open access
Powered by Google Translator Translator

Endocrinology (all articles)

[Abstract Only] Randomized Trial: Evaluation of a Closed-loop System that Automates Insulin Delivery in Patients with Type 1 Diabetes

17 Oct, 2019 | 08:30h | UTC

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries: Artificial pancreas system better controls blood glucose levels than current technology – NIH News Releases (free)

Related: Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis – The BMJ (free)

 


Report and Recommendations: Optimizing Postprandial Glucose Management in Adults With Insulin-Requiring Diabetes

17 Oct, 2019 | 08:32h | UTC

Optimizing Postprandial Glucose Management in Adults With Insulin-Requiring Diabetes: Report and Recommendations – Journal of the Endocrine Society (free)

News Release: Diabetes advances poised to help manage blood sugar after meals – The Endocrine Society (free)

 


[Abstract Only] Study: 20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia

17 Oct, 2019 | 08:27h | UTC

20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries: For Kids With Genetic Condition, Statins May Be Lifesavers – U.S. News (free) AND Starting Statin in Childhood Protects FH Hearts – MedPage Today (free registration required) AND Making the Case for Early Statins in Familial Hypercholesterolemia – Medscape (free registration required)

 


Analysis Suggests Statins for Primary Prevention has Marginal Benefits for Most People

17 Oct, 2019 | 08:26h | UTC

Statins for primary prevention of cardiovascular disease – The BMJ (free)

Commentaries: For most healthy people, benefits of statins ‘may be marginal at best’ – The BMJ (free) AND Expert reaction to benefits of statins for low risk patients – Science Media Centre (free) AND Statin Guidelines Continue to Perplex – NEJM Journal Watch (free)

 


Sodium-glucose Cotransporter Inhibitors in Type 2 Diabetes: Thinking Beyond Glucose Lowering

17 Oct, 2019 | 08:23h | UTC

Sodium-glucose cotransporter inhibitors in type 2 diabetes: thinking beyond glucose lowering – Canadian Medical Association Journal (free)

 


Systematic Review: Fluoxetine for Adults who are Overweight or Obese

16 Oct, 2019 | 10:30h | UTC

Fluoxetine for adults who are overweight or obese – Cochrane Library (free)

Summary: Fluoxetine for overweight or obese adults – Cochrane Library (free)

 


Review: Metabolic and Endocrine Consequences of Bariatric Surgery

16 Oct, 2019 | 08:36h | UTC

Metabolic and Endocrine Consequences of Bariatric Surgery – Frontiers in Endocrinology (free)

 


Updated NICE Guideline: Diabetic Foot Problems

15 Oct, 2019 | 10:47h | UTC

Diabetic foot problems: prevention and management – National Institute for Health and Care Excellence (free)

Related: The management of diabetic foot: A clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine (free) AND Diabetic foot – The BMJ (free) AND Diagnosis and Management of Diabetic Foot Complications – American Diabetes Association (free) AND Prevention, assessment, diagnosis and management of diabetic foot based on clinical practice guidelines: A systematic review – Medicine (free)

 


Position Statement: Treatment of Hyperglycemia in Patients with Type 2 Diabetes and Impaired Renal Function

15 Oct, 2019 | 08:38h | UTC

Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on “The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function” – Nutrition, Metabolism & Cardiovascular Diseases (free)

Related: New ADA 2020 Guidelines for the Management of Diabetes (free)

 


Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis—Literature Review

15 Oct, 2019 | 08:23h | UTC

Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis—Literature Review – Frontiers in Medicine (free)

 


Extrahepatic Complications of Non-alcoholic Fatty Liver Disease

15 Oct, 2019 | 08:14h | UTC

Extrahepatic complications of non-alcoholic fatty liver disease – Revista de Gastroenterología de México (free)

 


Study: Non-alcoholic Fatty Liver Disease and Risk of Incident Acute Myocardial Infarction and Stroke

15 Oct, 2019 | 08:08h | UTC

Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults – The BMJ (free)

 


Opinion: Bacon Rashers, Statistics, and Controversy

14 Oct, 2019 | 08:37h | UTC

Bacon Rashers, Statistics, and Controversy – The BMJ Opinion (free)

Original Article: Guideline: It Is NOT Necessary to Reduce Red and Processed Meat Consumption (free guideline and systematic reviews)

Related: Meat’s Bad for You! No, It’s Not! How Experts See Different Things in the Data – The New York Times (10 articles per month are free) AND Is eating beef healthy? The new fight raging in nutrition science, explained. – Vox (free) AND Scientist Who Discredited Meat Guidelines Didn’t Report Past Food Industry Ties – The New York Times (10 articles per month are free)

 


Systematic Review of Guidelines: Non-pharmacological Interventions for Osteoporosis Treatment

14 Oct, 2019 | 08:32h | UTC

Non-pharmacological interventions for osteoporosis treatment: Systematic review of clinical practice guidelines – Osteoporosis and Sarcopenia (free)

 


European Panel Recommends Four-week Limit for the Use of High-strength Estradiol Creams

14 Oct, 2019 | 07:55h | UTC

PRAC recommends four-week limit for use of high-strength estradiol creams – European Medicines Agency (free)

Commentary: EU Panel: Don’t Use Estradiol Creams for Longer Than 4 Weeks – Medscape (free registration required)

 


Cohort Study: 10% Weight Loss May Cause Remission of Type 2 Diabetes

10 Oct, 2019 | 09:25h | UTC

Behaviour change, weight loss and remission of Type 2 diabetes: a community‐based prospective cohort study – Diabetic Medicine (free)

Commentaries: Type 2 diabetes remission possible with ‘achievable’ weight loss – University of Cambridge (free) AND 10% weight loss could send type 2 diabetes into remission – Medical News Today (free) AND Dieting Doesn’t Have to Be Drastic to Reverse Type 2 Diabetes – Medscape (free registration required)

 


[Abstract Only] Cohort Study: Use of Bisphosphonates and Risk of Osteonecrosis of the Jaw

10 Oct, 2019 | 09:14h | UTC

Use of oral bisphosphonates and risk of hospital admission with osteonecrosis of the jaw: Large prospective cohort study in UK women – Bone (link to abstract – $ for full-text)

Commentary: Bisphosphonates and the Risk of Osteonecrosis of the Jaw – RheumNow (free)

 


Meta-Analysis: Once-Weekly GLP-1 Receptor Agonist vs. SGLT-2 Inhibitors in Patients Inadequately Controlled with Oral Antidiabetic Drugs

10 Oct, 2019 | 09:13h | UTC

Comparative efficacy of once-weekly semaglutide versus SGLT-2 inhibitors in patients inadequately controlled with one to two oral antidiabetic drugs: a systematic literature review and network meta-analysis – The BMJ Open (free)

 


ACOG Committee Opinion: Screening and Management of the Hyperandrogenic Adolescent

9 Oct, 2019 | 10:45h | UTC

Screening and Management of the Hyperandrogenic Adolescent – American College of Obstetrics & Gynecology (free)

 


[Abstract Only] Observational Study Suggests that Guidelines from the Canadian Cardiovascular Society, ACC/AHA, and NICE Provide Better Guidance for Statin Use than Other Guidelines

9 Oct, 2019 | 10:37h | UTC

Statin Use in Primary Prevention of Atherosclerotic Cardiovascular Disease According to 5 Major Guidelines for Sensitivity, Specificity, and Number Needed to Treat – JAMA Cardiology (link to abstract – $ for full-text)

Commentary: Statin Use in Primary Prevention of ASCVD According to 5 Guidelines – American College of Cardiology (free)

 


Meta-Analysis: Age at Natural Menopause and Risk of Incident Cardiovascular Disease

8 Oct, 2019 | 10:11h | UTC

Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data – The Lancet Public Health (free)

Commentaries: Early menopause and risk of cardiovascular disease: an issue for young women – The Lancet Public Health (free) AND Early menopause predictor of heart disease – University of Queensland (free)

 


[Abstract Only] Cohort Studies: Effects of Sugary Beverages and Artificially Sweetened Beverages on the Risk of Type 2 Diabetes

8 Oct, 2019 | 10:10h | UTC

Changes in Consumption of Sugary Beverages and Artificially Sweetened Beverages and Subsequent Risk of Type 2 Diabetes: Results From Three Large Prospective U.S. Cohorts of Women and Men – Diabetes Care (link to abstract – $ for full-text)

Commentaries: Drinking more sugary beverages of any type may increase type 2 diabetes risk – Harvard T.H. Chan School of Public Health (free) AND Even naturally sweet drinks may increase diabetes risk – Medical News Today (free)

 


Consensus Recommendations for Management of Patients with Type 2 Diabetes Mellitus and Cardiovascular Diseases

8 Oct, 2019 | 09:38h | UTC

Consensus recommendations for management of patients with type 2 diabetes mellitus and cardiovascular diseases – Diabetology & Metabolic Syndrome (free)

Related: 2019 ESC Guidelines on Diabetes, Pre-diabetes, and Cardiovascular Diseases (free)

 


Global Atlas on Childhood Obesity

7 Oct, 2019 | 06:01h | UTC

Global Atlas on Childhood Obesity – World Obesity Federation (free PDF)

Commentaries: The world will have more than 250 million obese kids by 2030, a new report warns – CNN (free) AND 250 million children worldwide forecast to be obese by 2030 – The Guardian (free)

Related: Taking action on childhood obesity report – World Health Organization (free PDF) AND Report: Tenfold increase in childhood and adolescent obesity in four decades – World Health Organization / The Lancet (free)

 


Guideline Synopsis: Primary Prevention of Cardiovascular Disease

7 Oct, 2019 | 05:54h | UTC

Primary Prevention of Cardiovascular Disease – JAMA (free for a limited period)

Original Guideline: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease (free guideline and resources)

Related Summaries: The ABCs of Primary Cardiovascular Prevention: 2019 Update – American College of Cardiology (free) AND Key Points From the 2019 ACC/AHA Guidelines on the Primary Prevention of Cardiovascular Disease – American College of Cardiology (free)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.